Eugene G Schildknecht

Title: The Innovations of Eugene G Schildknecht

Introduction

Eugene G Schildknecht is a notable inventor based in Hackettstown, NJ (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of anticoccidial compositions. With a total of 5 patents, his work has had a meaningful impact on the treatment and prevention of coccidiosis in animals.

Latest Patents

Schildknecht's latest patents include innovative compositions that combine the antibiotic frenolicin B with various anticoccidial agents. One of his patents discloses a mixture of frenolicin B with a potentiated sulfonamide anticoccidial agent, which is useful for treating and preventing coccidiosis in animals. Another patent features a composition that combines frenolicin B with halofuginone hydrobromide, also aimed at addressing coccidiosis in animals.

Career Highlights

Eugene G Schildknecht has been associated with Hoffmann-La Roche Inc., where he has contributed to the advancement of veterinary pharmaceuticals. His expertise in developing effective treatments for animal health has established him as a respected figure in his field.

Collaborations

Throughout his career, Schildknecht has collaborated with notable colleagues, including Govind G Untawale and Gianpaolo Maestrone. These partnerships have fostered innovation and enhanced the quality of research in anticoccidial treatments.

Conclusion

Eugene G Schildknecht's contributions to veterinary medicine through his patents and collaborations highlight his dedication to improving animal health. His work continues to influence the industry and offers valuable solutions for the treatment of coccidiosis in animals.